Immuno-Oncology Therapy Market Size, Share, Growth, and Industry Analysis, By Type (Monoclonal Antibodies, Immune Checkpoint Inhibitors, Immune System Modulators, Cancer Vaccines), By Application (Hospitals, Ambulatory Surgical Center, Others), and Regional Forecast From 2025 To 2033

Last Updated: 21 July 2025
SKU ID: 21658992
ask for customization Buy Now
ask for customization Request a FREE Sample PDF

Detailed TOC of Global Immuno-oncology Therapy Industry Research Report, Growth Trends and Competitive Analysis 2033

  1. 1 Report Overview
    1. Study Scope
    2. Market Analysis by Type
      1. Global Immuno-oncology Therapy Market Size Growth Rate by Type: 2017 VS 2021 VS 2033
      2. Monoclonal Antibodies
      3. Immune Checkpoint Inhibitors
      4. Immune System Modulators
      5. Cancer Vaccines
    3. Market by Application
      1. Global Immuno-oncology Therapy Market Growth Rate by Application: 2017 VS 2021 VS 2033
      2. Hospitals
      3. Ambulatory Surgical Center
      4. Others
    4. Study Objectives
    5. Years Considered
  2. Market Perspective
    1. Global Immuno-oncology Therapy Market Size (2017-2033)
    2. Immuno-oncology Therapy Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2033
    3. Global Immuno-oncology Therapy Market Size by Region (2017-2022)
    4. Global Immuno-oncology Therapy Market Size Forecast by Region (2023-2033)
    5. Global Top Immuno-oncology Therapy Countries Ranking by Market Size
  3. Immuno-oncology Therapy Competitive by Company
    1. Global Immuno-oncology Therapy Revenue by Players
      1. Global Immuno-oncology Therapy Revenue by Players (2017-2022)
      2. Global Immuno-oncology Therapy Market Share by Players (2017-2022)
    2. Global Immuno-oncology Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3. Company Covered: Ranking by Immuno-oncology Therapy Revenue
    4. Global Immuno-oncology Therapy Market Concentration Ratio
      1. Global Immuno-oncology Therapy Market Concentration Ratio (CR5 and HHI)
      2. Global Top 10 and Top 5 Companies by Immuno-oncology Therapy Revenue in 2021
    5. Global Immuno-oncology Therapy Key Players Head office and Area Served
    6. Key Players Immuno-oncology Therapy Product Solution and Service
    7. Date of Enter into Immuno-oncology Therapy Market
    8. Mergers & Acquisitions, Expansion Plans
  4. Global Immuno-oncology Therapy Breakdown Data by Type
    1. Global Immuno-oncology Therapy Historic Revenue by Type (2017-2022)
    2. Global Immuno-oncology Therapy Forecasted Revenue by Type (2023-2033)
  5. Global Immuno-oncology Therapy Breakdown Data by Application
    1. Global Immuno-oncology Therapy Historic Market Size by Application (2017-2022)
    2. Global Immuno-oncology Therapy Forecasted Market Size by Application (2023-2033)
  6. North America
    1. North America Immuno-oncology Therapy Revenue by Company (2020-2022)
    2. North America Immuno-oncology Therapy Revenue by Type (2017-2033)
    3. North America Immuno-oncology Therapy Revenue by Application (2017-2033)
    4. North America Immuno-oncology Therapy Revenue by Country (2017-2033)
      1. United States
      2. Canada
  7. Europe
    1. Europe Immuno-oncology Therapy Revenue by Company (2020-2022)
    2. Europe Immuno-oncology Therapy Revenue by Type (2017-2033)
    3. Europe Immuno-oncology Therapy Revenue by Application (2017-2033)
    4. Europe Immuno-oncology Therapy Revenue by Country (2017-2033)
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Russia
  8. Asia Pacific
    1. Asia Pacific Immuno-oncology Therapy Revenue by Company (2020-2022)
    2. Asia Pacific Immuno-oncology Therapy Revenue by Type (2017-2033)
    3. Asia Pacific Immuno-oncology Therapy Revenue by Application (2017-2033)
    4. Asia Pacific Immuno-oncology Therapy Revenue by Region (2017-2033)
      1. China
      2. Japan
      3. South Korea
      4. India
      5. Australia
      6. China Taiwan
      7. Indonesia
      8. Thailand
      9. Malaysia
  9. Latin America
    1. Latin America Immuno-oncology Therapy Revenue by Company (2020-2022)
    2. Latin America Immuno-oncology Therapy Revenue by Type (2017-2033)
    3. Latin America Immuno-oncology Therapy Revenue by Application (2017-2033)
    4. Latin America Immuno-oncology Therapy Revenue by Country (2017-2033)
      1. Mexico
      2. Brazil
      3. Argentina
  10. Middle East and Africa
    1. Middle East and Africa Immuno-oncology Therapy Revenue by Company (2020-2022)
    2. Middle East and Africa Immuno-oncology Therapy Revenue by Type (2017-2033)
    3. Middle East and Africa Immuno-oncology Therapy Revenue by Application (2017-2033)
    4. Middle East and Africa Immuno-oncology Therapy Revenue by Country (2017-2033)
      1. Turkey
      2. Saudi Arabia
      3. UAE
  11. Company Profiles
    1. Amgen
      1. Amgen Company Details
      2. Amgen Business Overview
      3. Amgen Immuno-oncology Therapy Products and Services
      4. Amgen Immuno-oncology Therapy Revenue in Immuno-oncology Therapy Business (2017-2022)
      5. Amgen Immuno-oncology Therapy SWOT Analysis
      6. Amgen Recent Developments
    2. AstraZeneca
      1. AstraZeneca Company Details
      2. AstraZeneca Business Overview
      3. AstraZeneca Immuno-oncology Therapy Products and Services
      4. AstraZeneca Immuno-oncology Therapy Revenue in Immuno-oncology Therapy Business (2017-2022)
      5. AstraZeneca Immuno-oncology Therapy SWOT Analysis
      6. AstraZeneca Recent Developments
    3. Bristol-Myers Squibb
      1. Bristol-Myers Squibb Company Details
      2. Bristol-Myers Squibb Business Overview
      3. Bristol-Myers Squibb Immuno-oncology Therapy Products and Services
      4. Bristol-Myers Squibb Immuno-oncology Therapy Revenue in Immuno-oncology Therapy Business (2017-2022)
      5. Bristol-Myers Squibb Immuno-oncology Therapy SWOT Analysis
      6. Bristol-Myers Squibb Recent Developments
    4. Eli-Lilly
      1. Eli-Lilly Company Details
      2. Eli-Lilly Business Overview
      3. Eli-Lilly Immuno-oncology Therapy Products and Services
      4. Eli-Lilly Immuno-oncology Therapy Revenue in Immuno-oncology Therapy Business (2017-2022)
      5. Eli-Lilly Immuno-oncology Therapy SWOT Analysis
      6. Eli-Lilly Recent Developments
    5. Roche
      1. Roche Company Details
      2. Roche Business Overview
      3. Roche Immuno-oncology Therapy Products and Services
      4. Roche Immuno-oncology Therapy Revenue in Immuno-oncology Therapy Business (2017-2022)
      5. Roche Immuno-oncology Therapy SWOT Analysis
      6. Roche Recent Developments
    6. GlaxoSmithKline
      1. GlaxoSmithKline Company Details
      2. GlaxoSmithKline Business Overview
      3. GlaxoSmithKline Immuno-oncology Therapy Products and Services
      4. GlaxoSmithKline Immuno-oncology Therapy Revenue in Immuno-oncology Therapy Business (2017-2022)
      5. GlaxoSmithKline Immuno-oncology Therapy SWOT Analysis
      6. GlaxoSmithKline Recent Developments
    7. Janssen Biotech
      1. Janssen Biotech Company Details
      2. Janssen Biotech Business Overview
      3. Janssen Biotech Immuno-oncology Therapy Products and Services
      4. Janssen Biotech Immuno-oncology Therapy Revenue in Immuno-oncology Therapy Business (2017-2022)
      5. Janssen Biotech Immuno-oncology Therapy SWOT Analysis
      6. Janssen Biotech Recent Developments
    8. Merck
      1. Merck Company Details
      2. Merck Business Overview
      3. Merck Immuno-oncology Therapy Products and Services
      4. Merck Immuno-oncology Therapy Revenue in Immuno-oncology Therapy Business (2017-2022)
      5. Merck Immuno-oncology Therapy SWOT Analysis
      6. Merck Recent Developments
    9. Novartis
      1. Novartis Company Details
      2. Novartis Business Overview
      3. Novartis Immuno-oncology Therapy Products and Services
      4. Novartis Immuno-oncology Therapy Revenue in Immuno-oncology Therapy Business (2017-2022)
      5. Novartis Immuno-oncology Therapy SWOT Analysis
      6. Novartis Recent Developments
    10. Pfizer
      1. Pfizer Company Details
      2. Pfizer Business Overview
      3. Pfizer Immuno-oncology Therapy Products and Services
      4. Pfizer Immuno-oncology Therapy Revenue in Immuno-oncology Therapy Business (2017-2022)
      5. Pfizer Immuno-oncology Therapy SWOT Analysis
      6. Pfizer Recent Developments
    11. Sanofi
      1. Sanofi Company Details
      2. Sanofi Business Overview
      3. Sanofi Immuno-oncology Therapy Products and Services
      4. Sanofi Immuno-oncology Therapy Revenue in Immuno-oncology Therapy Business (2017-2022)
      5. Sanofi Recent Developments
    12. Spectrum Pharmaceuticals
      1. Spectrum Pharmaceuticals Company Details
      2. Spectrum Pharmaceuticals Business Overview
      3. Spectrum Pharmaceuticals Immuno-oncology Therapy Products and Services
      4. Spectrum Pharmaceuticals Immuno-oncology Therapy Revenue in Immuno-oncology Therapy Business (2017-2022)
      5. Spectrum Pharmaceuticals Recent Developments
    13. Takeda
      1. Takeda Company Details
      2. Takeda Business Overview
      3. Takeda Immuno-oncology Therapy Products and Services
      4. Takeda Immuno-oncology Therapy Revenue in Immuno-oncology Therapy Business (2017-2022)
      5. Takeda Recent Developments
    14. BioNTech SE
      1. BioNTech SE Company Details
      2. BioNTech SE Business Overview
      3. BioNTech SE Immuno-oncology Therapy Products and Services
      4. BioNTech SE Immuno-oncology Therapy Revenue in Immuno-oncology Therapy Business (2017-2022)
      5. BioNTech SE Recent Developments
    15. Allogene Therapeutics
      1. Allogene Therapeutics Company Details
      2. Allogene Therapeutics Business Overview
      3. Allogene Therapeutics Immuno-oncology Therapy Products and Services
      4. Allogene Therapeutics Immuno-oncology Therapy Revenue in Immuno-oncology Therapy Business (2017-2022)
      5. Allogene Therapeutics Recent Developments
    16. IMAB-I-Mab Biopharma Co., Ltd.
      1. IMAB-I-Mab Biopharma Co., Ltd. Company Details
      2. IMAB-I-Mab Biopharma Co., Ltd. Business Overview
      3. IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Products and Services
      4. IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Revenue in Immuno-oncology Therapy Business (2017-2022)
      5. IMAB-I-Mab Biopharma Co., Ltd. Recent Developments
    17. Arcus Biosciences
      1. Arcus Biosciences Company Details
      2. Arcus Biosciences Business Overview
      3. Arcus Biosciences Immuno-oncology Therapy Products and Services
      4. Arcus Biosciences Immuno-oncology Therapy Revenue in Immuno-oncology Therapy Business (2017-2022)
      5. Arcus Biosciences Recent Developments
    18. Gritstone Oncology
      1. Gritstone Oncology Company Details
      2. Gritstone Oncology Business Overview
      3. Gritstone Oncology Immuno-oncology Therapy Products and Services
      4. Gritstone Oncology Immuno-oncology Therapy Revenue in Immuno-oncology Therapy Business (2017-2022)
      5. Gritstone Oncology Recent Developments
    19. Autolus Therapeutics
      1. Autolus Therapeutics Company Details
      2. Autolus Therapeutics Business Overview
      3. Autolus Therapeutics Immuno-oncology Therapy Products and Services
      4. Autolus Therapeutics Immuno-oncology Therapy Revenue in Immuno-oncology Therapy Business (2017-2022)
      5. Autolus Therapeutics Recent Developments
    20. Rubius Therapeutics
      1. Rubius Therapeutics Company Details
      2. Rubius Therapeutics Business Overview
      3. Rubius Therapeutics Immuno-oncology Therapy Products and Services
      4. Rubius Therapeutics Immuno-oncology Therapy Revenue in Immuno-oncology Therapy Business (2017-2022)
      5. Rubius Therapeutics Recent Developments
  12. Immuno-oncology Therapy Market Dynamics
    1. Immuno-oncology Therapy Market Trends
    2. Immuno-oncology Therapy Market Drivers
    3. Immuno-oncology Therapy Market Challenges
    4. Immuno-oncology Therapy Market Restraints
  13. Research Findings and Conclusion
  14. Appendix
    1. Research Methodology
      1. Methodology/Research Approach
      2. Data Source
    2. Author Details